This topic contains a solution. Click here to go to the answer

Author Question: A client has had a cerebral vascular accident and has lost visual acuity. When planning care, the ... (Read 19 times)

Zulu123

  • Hero Member
  • *****
  • Posts: 525
A client has had a cerebral vascular accident and has lost visual acuity. When planning care, the nurse should provide a(n):
 
  a. raised speaking voice when talking to the client to make up for the deficit.
  b. means by which the client can communicate his needs.
  c. way to compensate for the client's loss of vision.
  d. active range-of-motion exercises for all extremities.

Question 2

A client has developed septicemia and lapsed into unconsciousness. Her family stays with her around the clock. The nurse should encourage the family to:
 
  a. stay back from the bed so as not to disturb the client or be in the way.
  b. quietly and lightly touch and stroke the client.
  c. talk to and touch the client as if she were conscious.
  d. dim the lights and keep noise to a minimum.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Dunkey

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

ANS: C

Answer to Question 2

ANS: C




Zulu123

  • Member
  • Posts: 525
Reply 2 on: Jul 22, 2018
YES! Correct, THANKS for helping me on my review


Dnite

  • Member
  • Posts: 297
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library